US biotechnology company Moderna is set to move its UK headquarters to the Reflector building at TRIBECA in King’s Cross – London’s largest purpose-built life sciences campus.
TRIBECA, London
TRIBECA developer Reef + Partners and investor BlackRock Real Estate have announced that Moderna will occupy around 4,206 sq ft, with fit-out works expected to be completed by the end of April 2027.
The move expands Moderna’s UK presence in London, complementing its existing footprint, which includes the Moderna Innovation and Technology Centre at the Harwell Campus in Oxfordshire.
“The UK is a key market for Moderna and expanding our footprint with space at TRIBECA marks another step in our long-term commitment to the country’s vibrant life sciences ecosystem,” said Darius Hughes, UK general manager at Moderna.
“With TRIBECA positioned at the heart of London’s Knowledge Quarter, it puts us in close proximity to many of the country’s leading scientific and research institutions, making it a great environment for our continued growth and the further development of our mRNA platform.”
TRIBECA is being delivered in two phases, the first of which, The Apex, comprises over 110,000 sq ft of laboratory space, where the London BioScience Innovation Centre (LBIC) has taken 33,000 sq ft and the Francis Crick Institute is collaborating on 52,000 sq ft of space.
Peter Langly-Smith, managing director at Reef + Partners, said: “We are focused on creating a campus where leading innovative businesses can come together, collaborate and grow, with a shared purpose of advancing the human condition.”
